GlassScriptPhysician profile
Adlah Sukkar
NPI 1548362791
$3,551.14
in general payments reported to CMS, 2019-2025
30 companies · $370 in 2025
The $370 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $604 · 2020: $451 · 2021: $44.33 · 2022: $905 · 2023: $585 · 2024: $592 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,546.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $555.89 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Glaxosmithkline, LLC. | $418.24 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $396.41 | 2019-2025 | Jascayd |
| Pulmonx Corporation | $352.42 | 2023-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Astrazeneca Pharmaceuticals LP | $306.86 | 2019-2024 | Fasenra, Airsupra, Breztri |
| Electromed, INC. | $253.19 | 2023-2025 | Smartvest |
| Baxter Healthcare | $122.74 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Insmed, INC. | $117.42 | 2022-2025 | Arikayce |
| Genzyme Corporation | $115.16 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $98.44 | 2020-2025 | Opsumit |
| Regeneron Healthcare Solutions, INC. | $93.73 | 2019-2023 | Dupixent |
| Amgen INC. | $88.00 | 2022-2025 | Tezspire |
| Janssen Pharmaceuticals, INC | $66.32 | 2019-2022 | |
| Mylan Specialty L.P. | $64.48 | 2020-2022 | |
| Pfizer INC. | $59.61 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $54.69 | 2019-2022 | |
| Shionogi INC | $51.48 | 2023-2025 | Fetroja |
| Grifols USA, LLC | $47.37 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.55 | 2022 | |
| Novartis Pharmaceuticals Corporation | $31.75 | 2019-2024 | |
| Genentech USA, INC. | $30.60 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $29.42 | 2022 | |
| Alcresta Therapeutics, INC. | $28.91 | 2022 | |
| United Therapeutics Corporation | $24.39 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.01 | 2019 | |
| Medical Graphics Corporation | $20.32 | 2022 | |
| Vapotherm INC | $18.65 | 2022 | |
| Sunovion Pharmaceuticals INC. | $16.13 | 2019 | |
| Merck Sharp & Dohme LLC | $15.63 | 2020 | |
| Gilead Sciences, INC. | $15.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adlah Sukkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.